Clinical trial
Sopran - Omeprazole Treatment Versus Surgery
NCT00256737 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00256737 |
|---|---|
| Title | Sopran - Omeprazole Treatment Versus Surgery |
| Official title | Omeprazole Versus Anti-reflux Surgery in the Long-term Management of Peptic Esophagitis - a 10 Year Follow up Study of Patients Previously Studied for 5 Years - A Nordic Multicentre Study |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | GERD |
| Intervention type | Drug |
| Interventions | Omeprazole |
| Enrollment | 219 |
| Start date | Jan 1, 1998 |
| Primary completion | Oct 1, 2005 |
| Completion | Oct 1, 2005 |
| First posted | Nov 22, 2005 |
| Last update posted | Jan 24, 2011 |
| Countries | Denmark, Finland, Norway, Sweden |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: